MEDICINOVA Stock Quote

$6.77 arrow  Change: 0.23 %Chge: 3.52% Vol: 1,487
End Of Day Prices
High: 6.82 | Low: 6.63 | Open: 6.63 | Close: 6.77
52 Wk High: 7.8 | 52 Wk Low: 4.38 | Todays Pivot: 6.52
Sector: add stock to watch list

MNOV Chart


You need Flash Player to see the chart, please download from the link below

Get Adobe Flash player

Online News For Medicinova

MediciNova Appoints Hideki Nagao To Its Board Of Directors

LA JOLLA, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:4875), today announced the appointment of Mr ...


Ibudilast Reduces Secondary Progressive Multiple Sclerosis Brain Atrophy By 67% Over Placebo In 2-Year Study. Is MediciNova A Takeover Target?

Recent studies have shown that it also has activity in treating alcohol and methamphetamine addiction, ALS, and MS. On October 28, Dr. Robert Fox in Paris presented MNOV's two-year phase 2b Ibudilast primary endpoint results, in 255 SPMS and PPMS patients.


New Relic (NEWR) Investors: JMP Securities Keeps Market Outperform Rating, Sees $56/Share; Medicinova Has 1.46 Sentiment

Bank Of America Corp De, a North Carolina-based fund reported 6,459 shares. About 400 shares traded. MediciNova, Inc. (MNOV) has declined 6.61% since November 8, 2016 and is downtrending. It has underperformed by 23.31% the S&P500.


Salesforce.com Inc (NYSE:CRM) Stock Rating Upgraded by Vetr Inc

(NASDAQ:MNOV) for 3,327 shares. Since May 18, 2017, it had 1 insider buy, and 61 insider sales for $82.90 million activity. 36,000 shares valued at $6.14M were sold by LEINWEBER LARRY D on Thursday, June 1. Shares for $734,787 were sold by Harris Parker.


MediciNova's ibudilast successful in mid-stage MS study; shares ahead 18% premarket

Thinly traded micro cap MediciNova (NASDAQ:MNOV) is up 18% premarket on increased volume in response to its announcement of positive results from a 255-subject Phase 2b clinical trial assessing MN-166 (ibudilast) in patients with progressive multiple ...



Want To Add This Quote To Your Site?

With our stock widgets you can add a Medicinova quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for MNOV to choose from. Visit here to build your stock quote widget »